Kelly Brett is an accomplished leader in the pharmaceutical and biotechnology industries, currently serving as the Head of Sales and Account Management for Type 1 Diabetes at Vertex Pharmaceuticals since August 2025. Previously, Kelly held the position of Vice President of Commercial Operations & Patient Services, as well as Senior Director of Sales at Sage Therapeutics from March 2022 to August 2025. Prior experience includes roles at Biogen, Provention Bio, and multiple positions at Novo Nordisk, where notable achievements include numerous awards for sales excellence and leadership. Kelly's career began at Boehringer Ingelheim, with accomplishments in cardio-pulmonary specialty sales, and has also encompassed business analysis and human resources roles at Electronic Data Systems, IBM, and VisionAIR. Kelly holds a Bachelor of Arts in Psychology from the University of North Carolina Wilmington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices